Editorial Board
Editor-In-Chief
Paul E. Sax, MD, is Clinical Director of the Division of Infectious Diseases at Brigham and Women's Hospital and Professor of Medicine at Harvard Medical School. He holds the Bruce A. Beal and Robert L. Beal Distinguished Chair in Infectious Diseases. He is a Section Editor for the HIV/AIDS Section of UpToDate, is a member of the HIV treatment guidelines panel for the International Antiviral Society – USA, and is on the Editorial Board of NEJM Journal Watch Infectious Diseases, where he writes the popular column HIV and ID Observations. An internationally recognized clinician and clinical teacher in infectious diseases (in particular HIV), Dr. Sax also is involved in clinical research, including trials of antiretroviral therapies, cost-effectiveness of management strategies for HIV, and assessments of toxicity of antiretroviral therapy. Find Dr. Sax on Bluesky @PaulSaxMD.bsky.social
Deputy Editors
Kimberly Hanson, MD, MHS is a Professor of Medicine and Pathology at the University of Utah. Administratively, Dr. Hanson serves as the Director of the Immuncompromised Host Infectious Diseases Service and is Head of the Mycology Section within ARUP Laboratories. Her clinical and research interests involve the development and validation of novel diagnostic tests with a focus on opportunistic infections.
Susanna Naggie, MD, FIDSA, is a Professor of Medicine and currently holds appointments at the Duke University School of Medicine, the Duke Clinical Research Institute and the Durham Veterans Affairs Medical Center. Dr. Naggie is a clinical investigator with a focus in clinical trials in infectious diseases and translational science in HIV and liver disease. She is a standing member of the DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents and the CDC/NIH/IDSA-HIVMA Opportunistic Infections Guideline. She is the Vice Dean for Clinical Research and Interim Director for the Duke Clinical and Translational Sciences Institute.
David A. Pegues, MD, is Professor of Medicine in the Division of Infectious Diseases at the Perelman School of Medicine at the University of Pennsylvania, Medical Director of Healthcare Epidemiology, Infection Prevention and Control and Co-Director of the Antimicrobial Stewardship Program at the Hospital of the University of Pennsylvania. His interests include device-associated infections; novel infection control technologies to reduce microbial contamination of the environment; and antimicrobial and testing stewardship interventions to improve clinical outcomes.
Maunank Shah, MD, PhD, is a Professor in the Division of Infectious Diseases at Johns Hopkins University, where he also co-directs the medical student course on microbiology and infectious diseases at Johns Hopkins School of Medicine. Dr. Shah additionally serves as medical director for the Baltimore City Health Department TB program, directs the Johns Hopkins Center for Infectious Diseases Education, Advancement, and Learning (IDEAL), and is past-President of the National Society of TB Clinicians. He has led studies to evaluate the performance and implementation of novel TB diagnostic tools in resource-limited settings, and been involved in WHO TB guideline development related to TB diagnostics. His continuing multidisciplinary research efforts focus on public health interventions to reduce TB transmission, patient-centered approaches to TB treatment adherence, as well as mathematical modeling and economic evaluation of HIV and TB interventions. He is co-inventor of HIV-ASSIST, a decision-support tool to support clinicians in ARV selection.
Associate Editors
Jose R. Arribas, MD, is the head of the Internal Medicine Department at La Paz University Hospital and Professor of Medicine at the Autonoma University Medical School, both in Madrid, Spain. His research interests are focused on antiretroviral therapy, development of new antiretrovirals, biomarkers of aging in persons with HIV, and emerging infectious diseases. Find Dr. Arribas on X @jrarribas and Bluesky @jarribas.bsky.social.
Taison Bell, MD, is an Assistant Professor of Medicine in the divisions of Infectious Disease and Pulmonary/Critical Care Medicine at the University of Virginia. He is also Vice Chair for Faculty Affairs in the Department of Medicine and Director of the UVA Summer Medical Leadership Program (a medical school preparatory program for under-represented and disadvantaged students). Dr. Bell joined the faculty in 2017 after completing a critical care fellowship at the National Institutes of Health. Prior to that he completed internal medicine residency at the Massachusetts General Hospital—where he was a chief resident—and infectious disease fellowship at the combined Massachusetts General Hospital/Brigham and Women’s Hospital program. Find Dr. Bell on X @TaisonBell.
Christina Coyle, MD, MS, is a Professor of Medicine and Pathology at the Albert Einstein College of Medicine. She oversees an active Tropical Medicine Clinic in the Bronx, New York, and has extensive experience in tropical medicine and immigrant health. She is widely recognized as an expert on larval tapeworms, neurocysticercosis, and echinococcus, serving on both national and international committees for the disease.
Jason Gallagher, PharmD, is Clinical Professor at Temple University School of Pharmacy and Clinical Pharmacy Specialist in Infectious Diseases at Temple University Hospital. He also is the Director of the PGY2 Residency in Infectious Diseases Pharmacy at Temple, Editor-in-Chief of Contagion, and a past president of the Society of Infectious Diseases Pharmacists. His research focuses on the treatment of multidrug-resistant infections and methods of improving antimicrobial utilization. Find Dr. Gallagher on X @JGPharmD.
Emily L. Heil, PharmD, MS, is a Professor in the Department of Pharmacy Practice and Science at the University of Maryland School of Pharmacy and Co-Director of the Antimicrobial Stewardship Program at the University of Maryland Medical Center. Her research interests include antimicrobial stewardship interventions to improve clinical outcomes both in the U.S. and abroad, optimization of antimicrobial dosing in special populations, and infections in immunocompromised hosts. Find Dr. Heil on Bluesky @emilyLheil.bsky.social.
Romney Humphries, PhD, D(ABMM), is a Professor of Pathology, Microbiology and Immunology, Director of the Division of Laboratory Medicine, and Director of the Infectious Diseases Laboratories at Vanderbilt University Medical Center. Dr. Humphries is a Fellow of American Academy of Microbiology, an associate editor for the Journal of Clinical Microbiology, and a member of the Clinical and Laboratory Standards Institute. She is a widely recognized expert in diagnostic microbiology and antimicrobial resistance. Find Dr. Humphries on Bluesky@romneyintn.bsky.social
Vivek Jain, MD, MAS, FIDSA, is a Professor of Medicine in the Division of HIV, Infectious Diseases and Global Medicine at San Francisco General Hospital, University of California, San Francisco. He is the Director of the Infectious Diseases Clinic, Co-Director of the SFGH Infection Control team, works clinically on both the hospital ID consult team and in the HIV Clinic at SFGH, and teaches in the UCSF Global Health program. His research has focused on implementation science approaches to improving HIV care through ART expansion and the use of novel diagnostics for therapy monitoring. He has helped lead the SFGH response to the COVID-19 pandemic and mpox epidemic. Find Dr. Jain on X @VivekJainMD.
Ruvandhi Nathavitharana, MD, is an Assistant Professor at Beth Israel Deaconess Medical Center and Harvard Medical School. Dr. Nathavitharana’s research on tuberculosis is funded primarily by the U.S. National Institutes of Health and focuses on the use of implementation science to optimize TB diagnosis and improve TB care delivery in high TB incidence countries, with a focus on Peru and South Africa. Dr. Nathavitharana has served as a technical expert analyzing data to inform WHO guideline development group panel recommendations on the accuracy of line probe assays for the diagnosis of TB and the impact of the urine lipoarabinomannan test. Dr. Nathavitharana’s clinical efforts focus on the longitudinal, multidisciplinary care of patients with TB and non-tuberculous mycobacterial infections. Dr. Nathavitharana is the Co-Director of the Social Justice Pathway for the BIDMC Internal Medicine Residency. Dr. Nathavitharana also serves the Chair of TB Proof, an advocacy organization based in South Africa, whose mission seeks to combine stories and science to destigmatize TB and mobilize national and global resources to end TB. Find Dr. Nathavitharana on X @ruvandhi.
Jeremy Nel is a physician and infectious diseases specialist, and the head of infectious diseases at Helen Joseph Hospital and the University of the Witwatersrand. He is past president of the Infectious Diseases Society of South Africa, and an active member of the Southern African HIV Clinicians Society. He has published research in the fields of HIV, tuberculosis, nontuberculous mycobacteria, COVID and cryptococcal meningitis, and lead or participated in clinical trials in COVID-19, cryptococcal meningitis, and pneumonia therapeutics.
Luis Ostrosky-Zeichner, MD, received his medical degree from Universidad Nacional Autonoma de Mexico and completed his internal medicine residency at Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran and his infectious diseases fellowship at the University of Texas Health Science Center at Houston/MD Anderson Cancer Center combined program. He is currently a Professor of Medicine and Epidemiology and the Memorial Hermann Endowed Chair at the University of Texas Health Science Center at Houston, where he is appointed as the vice chairman of Medicine for Healthcare Quality and the Division Chief at the Division of Infectious Diseases. He also serves as Chief Epidemiology Officer for the Memorial Hermann Healthcare System. He has consulted for FDA and CDC. He has published more than 220 peer-reviewed articles and actively pursues translational and clinical research in medical mycology, transplant infectious diseases, healthcare epidemiology, and antimicrobial stewardship. Find Dr. Ostrosky-Zeichner on Bluesky @DrLuisO.bsky.social
Federico Perez, MD, MS, is a member of the Infectious Diseases Section at the VA Northeast Ohio Healthcare System and Associate Professor of Medicine at Case Western Reserve University in Cleveland, Ohio. He is also program director of the adult Infectious Diseases fellowship program at Case Western Reserve University School of Medicine. His research interests are in the mechanisms and clinical impact of infections caused by antibiotic resistant bacteria, particularly Gram-negative rods.
Adam J. Ratner, MD, MPH, is Professor of Pediatrics and Microbiology, Director of the Division of Pediatric Infectious Diseases, and Vice Chair of Academic Affairs in the Department of Pediatrics at NYU Grossman School of Medicine and Hassenfeld Children’s Hospital. His clinical and research interests center on important infections of childhood, including vaccine-preventable diseases. Dr. Ratner has served as chair of the Clinical Research and Field Studies in Infectious Diseases study section at NIH and as a member of the Board of Directors of the Pediatric Infectious Diseases Society. He is a current member of the Committee on Infectious Diseases of the American Academy of Pediatrics. Find Dr. Ratner on Bluesky @adamratnermd.bsky.social
Chanu Rhee, MD, MPH, is an Associate Professor of Population Medicine and Medicine at Harvard Medical School, Medical Director of Infection Control at at Brigham and Women’s Hospital and Associate Professor of Population Medicine and Medicine at Harvard Medical School, and a practicing infectious disease and critical care physician. He is internationally recognized for his expertise in the epidemiology, surveillance, diagnosis, prevention, and treatment of sepsis and infections in critically ill patients. Dr. Rhee's clinical and research interests also include infection control, antimicrobial resistance and stewardship, respiratory viral infections, and infections in immunocompromised patients. He has authored numerous influential studies that have leveraged large electronic health record datasets to inform clinical care, and inform public health and healthcare policy.
Nadine Rouphael, MSc, MD, is a Professor of Medicine in the Infectious Diseases Division, Department of Medicine at Emory University in Atlanta, Georgia. She has interest in therapeutic and vaccine clinical trials (e.g., pandemic influenza, Zika, Ebola, SARS-CoV-2), vaccine delivery methods, translational research on innate immunity and systems biology, challenge studies, and correlates of protection.
Michael J. Rybak, PharmD, MPH, PhD, is a Professor of Pharmacy and Director of the Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences. He is also an adjunct Professor of Medicine, Division of Infectious Diseases, School of Medicine, Wayne State University. Dr. Rybak is affiliated with the Detroit Medical Center and is a member of their antimicrobial stewardship committee. Dr. Rybak’s research focus is antimicrobial pharmacokinetics and pharmacodynamics and the assessment of infectious diseases health outcomes, including their relationships to bacterial resistance. He has an interest and expertise in the area of antibiotic combination therapy to improve patient outcomes and prevent the emergence of bacterial resistance.
Ilan S. Schwartz, MD, PhD, is an infectious diseases physician at Duke University, where he is also Medical Director of the Infectious Diseases Clinical Research Unit. His clinical and research interests are emerging fungal infections, transplant infectious disease, and global health. He is also interested in harnessing social media for medical education and is co-founder of the Twitter-based journal club, @IDJClub. Find Dr. Schwartz on X @GermHunterMD.
Monica Slavin leads a National Centre of Research Excellence in Infections in Cancer at University of Melbourne, Australia. She is Director of the Department of Infectious Diseases at Peter MacCallum Cancer Centre and of the Immunocompromised Host Infection Service at Royal Melbourne Hospital in Melbourne, Australia. Her research is in diagnosis and management of infections in the immunocompromised host with a particular interest in fungal infection. Find Dr. Slavin on X @monicaslavin and @NCICancer.
Emmanuel (Chip) Walter, MD, MPH is a Professor of Pediatrics in the Divisions of Infectious Diseases and General Pediatrics and Adolescent Health at Duke University School of Medicine in Durham, North Carolina. He is the Chief Medical Officer at the Duke Human Vaccine Institute where he directs the Vaccine and Trials Unit. His research is aimed at evaluating strategies to prevent, treat, and control human infectious diseases, assess the safety and effectiveness of new and existing vaccines, and further understanding of measures of protection from infection.
Associate Editor/Voices of ID Editor
Sara Hurtado Bares, MD, is an Associate Professor of Medicine at the University of Nebraska Medical Center in Omaha. She is the Associate Medical Director for the UNMC HIV Clinic, and her clinical and research interests are focused on improving the health of people with HIV with a focus on HIV-related comorbidities and women’s health. Find Dr. Bares on X at @shurtadobares.
Associate Editor for Supplements/Methodological and Statistical Editor
Jean-Jacques Parienti, MD, PhD, is a Professor of Medicine at Caen University Hospital, France. Dr. Parienti leads the Clinical Research Department as Medical Director. Dr. Parienti cares for outpatient people with HIV at the Infectious Diseases Department and helps investigators with their research design and analysis at the Methodological and Statistic platform. Dr. Parienti’s topics of research include antiretroviral therapies, biomarker-driven antibiotic stewardship, healthcare-associated infections and public health interventions to mitigate emerging infectious diseases. Find Dr. Parienti on X at @JjParienti, or Bluesky @JjParienti.bsky.social.
Cover Art Editors
Mary Grizzard
Michael Grizzard
Statistical Editors
Ashley L. Buchanan
Steven Cohen
Victor De Gruttola
Farzad Noubary
Histopathology Editors
Jeannette Guarner
Mary Klassen-Fischer
Managing Editor
Katherine Eberenz
[email protected]
Contact for Research Integrity and Publication Ethics Questions
Assistant Managing Editor
Blake Campbell
Supplements Specialist
Kiley Mead
Special Section Editors
In the Literature
Stan Deresinski
Photo Quiz/Arcanum
Anthony Amoroso
Priya Nori
David J. Riedel
State-of-the-Art Review Editors
Allan R. Tunkel, MD, PhD, MACP
Tara Vijayan, MD
Clinical Dilemmas in Infectious Diseases
Daniel Minter
Varun Phadke
Ethics Rounds
Olivia Kates
Timothy P. Lahey
Past Editors
Reviews of Infectious Diseases
Edward H. Kass, 1979-1989 (vols. 1-11)
Sydney M. Finegold, 1990-1991 (vols. 12 and 13)
Clinical Infectious Diseases
Sydney M. Finegold, 1992-1999 (vols. 14-29)
Sherwood L. Gorbach, 2000–2016 (vols. 30–63)
Robert T. Schooley, 2017-2022 (vols. 64-74)
Editorial Advisory Board
Brian K. Agan, Bethesda, Maryland
Jan M. Agosti, Seattle, Washington
Samuel L. Aitken, Houston, Texas
Murat Akova, Ankara, Turkey
Michael L. Alkan, Beer Sheva, Israel
David R. Andes, Madison, Wisconsin
Jason R. Andrews, Stanford, California
Spinello Antinori, Milan, Italy
Anucha Apisarnthanarak, Praumthani, Thailand
Ricardo Araujo, Porto, Portugal
Robert D. Arbeit, Boston, Massachusetts
Alejandro Arenas-Pinto, London, United Kingdom
Cesar A. Arias, Houston, Texas
Wendy Armstrong, Atlanta, Georgia
Michael H. Augenbraun, Brooklyn, New York
Paul G. Auwaerter, Baltimore, Maryland
Ritu Banerjee, Nashville, Tennessee
Stephen G. Baum, Bronx, New York
Arnold S. Bayer, Los Angeles, California
Roger J. Bedimo, Dallas, Texas
Robert Belknap, Denver, Colorado
Shalom Ben-Shimol, Beer Sheva, Israel
Jonathan Berman, North Bethesda, Maryland
Gregory P. Bisson, Philadelphia, Pennsylvania
Robert A. Bonomo, Cleveland, Ohio
Louis Bont, Utrecht, Netherlands
Marc J.M. Bonten, Utrecht, Netherlands
Helen W. Boucher, Boston, Massachusetts
David R. Boulware, Minneapolis, Minnesota
William R. Bowie, Vancouver, Canada
Heather Bradley, Atlanta, Georgia
Jared Bullard, Winnipeg, Canada
Steven D. Burdette, Dayton, Ohio
Karen Bush, Bloomington, Indiana
Thomas Butler, Miramar, Florida
André Cabié, Fort-de-France, Martinique
John M. Cafardi, Cincinnati, Ohio
Thomas B. Campbell, Aurora, Colorado
Ann Chahroudi, Atlanta, Georgia
Christina C. Chang, Melbourne, Australia
James D. Cherry, Los Angeles, California
Cheng-Hsun Chiu, Taoyuan, Taiwan
Cornelius J. Clancy, Pittsburgh, Pennsylvania
David B. Clifford, St. Louis, Missouri
Cheryl Cohen, Johannesburg, South Africa
Jonathan A. Colasanti, Atlanta, Georgia
Brian Conway, Vancouver, Canada
Benjamin J. Cowling, Pokfulam, Hong Kong
Ron Dagan, Beer Sheva, Israel
Nick Daneman, Toronto, Canada
Anindita Das, Canberra, Australia
Michael Z. David, Philadelphia, Pennsylvania
Annabelle de St. Maurice, Los Angeles, California
Sarah B. Doernberg, San Francisco, California
Yohei Doi, Pittsburgh, Pennsylvania
Pere Domingo, Barcelona, Spain
Curtis J. Donskey, Cleveland, Ohio
Kelly E. Dooley, Baltimore, Maryland
Robert A. Duncan, Burlington, Massachusetts
Michael W. Dunne, Old Saybrook, Connecticut
John R. Dyer, Perth, Australia
Dean D. Erdman, Atlanta, Georgia
Shelley N. Facente, San Francisco, California
Daniel S. Fierer, New York, New York
William A. Fischer, II, Chapel Hill, North Carolina
Jay A. Fishman, Boston, Massachusetts
Courtney V. Fletcher, Omaha, Nebraska
Anthony R. Flores, Houston, Texas
Nathan Ford, Geneva, Switzerland
Henry S. Fraimow, Camden, New Jersey
Lawrence D. Frenkel, Rockford, Illinois
Alicia M. Fry, Atlanta, Georgia
Luis Furuya-Kanamori, Acton, Australia
Monica Gandhi, San Francisco, California
Jose M. Gatell, Barcelona, Spain
Dale N. Gerding, Hines, Illinois
Sara Gianella Weibel, San Diego, California
Peter H. Gilligan, Chapel Hill, North Carolina
Matthew B. Goetz, Los Angeles, California
Dan M. Granoff, San Francisco, California
David E. Griffith, Tyler, Texas
Carlos G. Grijalva, Nashville, Tennessee
Giovanni Guaraldi, Modena, Italy
Huldrych F. Günthard, Zurich, Switzerland
Colleen Hadigan, Bethesda, Maryland
W. David Hardy, Los Angeles, California
Anthony D. Harris, Baltimore, Maryland
Patrick N.A. Harris, Brisbane, Australia
Rodrigo Hasbun, Houston, Texas
Frederick G. Hayden, Charlottesville, Virginia
Hans H. Hirsch, Basel, Switzerland
Thomas L. Holland, Durham, North Carolina
Edward W. Hook, Birmingham, Alabama
Leigh M. Howard, Nashville, Tennessee
Noreen A. Hynes, Baltimore, Maryland
Michael G. Ison, Chicago, Illinois
Ilesh Jani, Marracuene, Mozambique
Jorgen S. Jensen, Copenhagen, Denmark
Somchai Jongwutiwes, Bangkok, Thailand
Andre C. Kalil, Omaha, Nebraska
Mini Kamboj, New York, New York
Sheldon L. Kaplan, Houston, Texas
Adolf W. Karchmer, Boston, Massachusetts
Carol A. Kauffman, Ann Arbor, Michigan
Colleen F. Kelley, Atlanta, Georgia
James D. Kellner, Calgary, Canada
Brendan J. Kelly, Philadelphia, Pennsylvania
Jeffrey D. Klausner, Los Angeles, California
Keith P. Klugman, Seattle, Washington
Janak Koirala, Springfield, Illinois
Marin H. Kollef, St. Louis, Missouri
Dennis L. Kolson, Philadelphia, Pennsylvania
Shyam Kottilil, Baltimore, Maryland
Peter J. Krause, New Haven, Connecticut
Vincent Le Moing, Montpellier, France
William M. Lee, Dallas, Texas
Jeffrey L. Lennox, Atlanta, Georgia
Emil Lesho, Rochester, New York
Benjamin P. Linas, Boston, Massachusetts
Daniel J. Livorsi, Iowa City, Iowa
Per Ljungman, Stockholm, Sweden
Lisa E. Manhart, Seattle, Washington
Jennifer Manne-Goehler, Boston, Massachusetts
Vincent Marconi, Atlanta, Georgia
Christina M. Marra, Seattle, Washington
Jeanne M. Marrazzo, Birmingham, Alabama
Marianne Martinello, Sydney, Australia
Esteban Martinez, Barcelona, Spain
Henry Masur, Bethesda, Maryland
Kate McCarthy, Brisbane, Australia
Malkanthie I. McCormick, Lexington, Kentucky
Kenneth McIntosh, Boston, Massachusetts
Graeme Meintjes, Cape Town, South Africa
Jean Menotti, Lyon, France
Lynne M. Mofenson, Washington, District of Columbia
Brian T. Montague, Aurora, Colorado
Arnold S. Monto, Ann Arbor, Michigan
David R. Murdoch, Christchurch, New Zealand
Landon Myer, Cape Town, South Africa
Jean B. Nachega, Pittsburgh, Pennsylvania
Kathleen M. Neuzil, Baltimore, Maryland
Valerie L. Ng, Oakland, California
Lindsay E. Nicolle, Winnipeg, Canada
Ran Nir-Paz, Jerusalem, Israel
Amanda Noska, Duluth, Minnesota
Marina Nunez, Winston-Salem, North Carolina
Joseph G. Pastorek, Slidell, Louisiana
Mical Paul, Haifa, Israel
Christopher Payan, Brest, France
Ville Peltola, Turku, Finland
Juan M. Pericas, Barcelona, Spain
Joshua G. Petrie, Ann Arbor, Michigan
Pedro A. Piedra, Houston, Texas
Dylan Pillai, Calgary, Canada
Mathias W. Pletz, Jena, Germany
Raymund R. Razonable, Rochester, Minnesota
Randall R. Reves, Denver, Colorado
John H. Rex, Wellesley, Massachusetts
Frank S. Rhame, Minneapolis, Minnesota
Jurgen K. Rockstroh, Bonn, Germany
William R. Rodriguez, Boston, Massachusetts
Jesús Rodríguez-Baño, Sevilla, Spain
Keith A. Rodvold, Chicago, Illinois
Benjamin A. Rogers, Clayton, Australia
Stephen J. Rogerson, Parkville, Australia
Sarah E. Rowan, Denver, Colorado
Michael S. Saag, Birmingham, Alabama
Lisa Saiman, New York, New York
Max Salfinger, Tampa, Florida
Michael J. Satlin, New York, New York
Mark R. Schleiss, Minneapolis, Minnesota
Audrey N. Schuetz, Rochester, Minnesota
Jennifer E. Schuster, Kansas City, Missouri
John Scott, Seattle, Washington
Edward J. Septimus, Boston, Massachusetts
Irini Sereti, Bethesda, Maryland
Samuel Shelburne, Houston, Texas
Oguz Resat Sipahi, Izmir, Turkey
Graham M. Snyder, Pittsburgh, Pennsylvania
Andrej Spec, St. Louis, Missouri
Brad Spellberg, Los Angeles, California
Sandra A. Springer, New Haven, Connecticut
Serena S. Spudich, New Haven, Connecticut
Jack T. Stapleton, Iowa City, Iowa
Gina A. Suh, Rochester, Minnesota
Mark S. Sulkowski, Baltimore, Maryland
Andrew H. Talal, Buffalo, New York
Paul A. Tambyah, Singapore
Pierre Tattevin, Rennes, France
Elitza Theel, Rochester, Minnesota
Chloe L. Thio, Baltimore, Maryland
David L. Thomas, Baltimore, Maryland
George R. Thompson, Davis, California
Hidenori Toyoda, Ogaki, Japan
Barbara W. Trautner, Houston, Texas
Ephraim L. Tsalik, Durham, North Carolina
Susan Tuddenham, Baltimore, Maryland
Reinout van Crevel, Nijmegen, Netherlands
David van Duin, Chapel Hill, North Carolina
Fernando Vazquez, Oviedo, Spain
Pauline Vetter, Geneva, Switzerland
David H. Walker, Galveston, Texas
Xiu-Feng Wan, Columbia, Missouri
Richard R. Watkins, Akron, Ohio
A. Clinton White, Galveston, Texas
Mark H. Wilcox, Leeds, United Kingdom
Darcy A. Wooten, San Diego, California
Hugh Wright, Brisbane, Australia
Kwok-Yung Yuen, Hong Kong Special Administrative Region, China
Werner Zimmerli, Liestal, Switzerland
